Article Versions Notes

Kim J-E, Lee Y-J, Lee K-J, Park S-H, Kang H. Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance. International Journal of Molecular Sciences. 2022; 23(21):13228. https://doi.org/10.3390/ijms232113228

Kim, Jung-Eun, Yu-Jin Lee, Kyung-Jae Lee, Song-Hee Park, and Hoon Kang. 2022. "Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance" International Journal of Molecular Sciences 23, no. 21: 13228. https://doi.org/10.3390/ijms232113228

Kim, J.-E., Lee, Y.-J., Lee, K.-J., Park, S.-H., & Kang, H. (2022). Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance. International Journal of Molecular Sciences, 23(21), 13228. https://doi.org/10.3390/ijms232113228